The pharma ingredients disruptor

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jack Stine, Chief Executive Officer at Savendor.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jack, covering:

• What he learned about supplier relationship management from exposure to 70 supply chain sourcing teams in 3M
• The shift to sourcing APIs and excipients for generics and med devices under FDA regulations
• How he always wanted to start a business, take the plunge, and fall in love with being a founder
• The actual trend of secondary sourcing… as opposed to immediate switching
• And what is Minnesota nice?!

Since founding Savendor in 2023, Jack Stine has pioneered a new model for pharma sourcing teams to move faster, cut out intermediaries, added clients from 4 continents, and built an industry-leading portfolio of 331 pharmaceutical ingredient manufacturers. Savendor has been accepted into AstraZeneca’s Diverse and Small Business Mentorship Program and BetaMN’s startup accelerator. Jack has presented Savendor at both CPHI Philadelphia and CPHI Milan.

Jack has worked in sourcing for over a decade. His career has brought him to APIs, excipients, industrial products, services, food, and medical device components. He has shared his knowledge by leading the Negotiations Training Team at Boston Scientific and speaking to undergraduates at the University of Minnesota’s Carlson School of Management. Jack has a Supply Chain Management Degree from the University of Minnesota and an MBA from IE Business School. Beyond sourcing and supply chain, Jack volunteers his time at the Ukrainian American Community Center as he is passionate about supporting people affected by the war in Ukraine.

This episode of Molecule to Market is sponsored by Vetter, a global leader in aseptic filling solutions for injectable products in the pharmaceutical and biotech industries. Discover more about Vetter’s comprehensive services, from early-stage development to commercial production, and how they support clients in delivering high-quality therapies to the market.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.